Department of Chemistry, Zhejiang University, Hangzhou, 310027, People's Republic of China.
J Colloid Interface Sci. 2010 Sep 1;349(1):153-8. doi: 10.1016/j.jcis.2010.05.028. Epub 2010 May 15.
Novel multidrug nanoparticles were self-assembled from the random copolymer containing cytarabine and fluorodeoxyuridine. The multidrug copolymer carrying 28.7wt.% of cytarabine and 29.1wt.% of fluorodeoxyuridine was prepared by radical polymerization combined with enzymatic selective transesterification. Homopolymers of the two drugs were also synthesized by the same method. And the polymers were characterized by FTIR, (1)H NMR, and gel permeation chromatography (GPC). Self-assembly of the multidrug copolymer was verified by UV-vis and fluorescence spectroscopy. The morphology of nanoparticles formed from the copolymer was investigated by transmission electron microscopy (TEM) and dynamic light scattering (DLS), which indicated that the nanoparticles were regular spheres with a diameter of 133+/-28nm. In vitro drug release studies illustrated that the two synergistic anticancer agents could be simultaneously released from the multidrug nanoparticles.
新型多药纳米粒子是由含有阿糖胞苷和氟尿嘧啶的无规共聚物自组装而成。多药共聚物通过自由基聚合结合酶选择性酯交换合成,载有 28.7wt%的阿糖胞苷和 29.1wt%的氟尿嘧啶。两种药物的均聚物也通过相同的方法合成。并通过傅里叶变换红外光谱(FTIR)、(1)H 核磁共振(NMR)和凝胶渗透色谱(GPC)对聚合物进行了表征。通过紫外-可见分光光度法和荧光光谱法验证了多药共聚物的自组装。通过透射电子显微镜(TEM)和动态光散射(DLS)研究了共聚物形成的纳米粒子的形态,结果表明纳米粒子为直径 133+/-28nm 的规则球体。体外药物释放研究表明,两种协同抗癌药物可以从多药纳米粒子中同时释放。